Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
A Review of Driver Genetic Alterations in Thyroid Cancers Publisher



Khatami F1 ; Tavangar SM2
Authors

Source: Iranian Journal of Pathology Published:2018


Abstract

Thyroid cancer is a frequent endocrine related malignancy with continuous increasing incidence. There has been moving development in understanding its molecular pathogenesis recently mainly through the explanation of the original role of several key signaling pathways and related molecular distributors. Central to these mechanisms are the genetic and epigenetic alterations in these pathways, such as mutation and DNA rearrangements. That does not mean, however, that all the somatic abnormalities here in a cancer genome have been involved in development of the cancer and just driver mutations are concerned in tumor initiation. By way of illustrations, MAPK pathway which is motivated by BRAFV600Eand RAS and RET/ PTC rearrangements are suggesting driver genetic alterations in follicular derived thyroid cancers which are considered in this review. © 2018, IRANIAN JOURNAL OF PATHOLOGY.
Related Docs
View other Related Docs
1. Genetic and Epigenetic of Medullary Thyroid Cancer, Iranian Biomedical Journal (2018)
2. Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma, Iranian Journal of Pathology (2019)
3. Personalized Treatment Options for Thyroid Cancer: Current Perspectives, Pharmacogenomics and Personalized Medicine (2019)
Experts (# of related papers)
View all Related Experts
Seyed Mohammad Tavangar (17)
Bagher Larijani (9)
Other Related Docs
4. Hypermethylated Rassf1 and Slc5a8 Promoters Alongside Brafv600e Mutation As Biomarkers for Papillary Thyroid Carcinoma, Journal of Cellular Physiology (2020)
5. Thyroid Cancer Research at Endocrinology and Metabolism Research Institute (Emri): A Report of Scientific Activities Between 2005 and 2020, Journal of Diabetes and Metabolic Disorders (2021)
6. Circulating Ctdna Methylation Quantification of Two Dna Methyl Transferases in Papillary Thyroid Carcinoma, Journal of Cellular Biochemistry (2019)
7. Liquid Biopsy in Thyroid Cancer: New Insight, International Journal of Hematology-Oncology and Stem Cell Research (2018)
8. Multiple Endocrine Neoplasia Syndromes From Genetic and Epigenetic Perspectives, Biomarker Insights (2018)
9. Meta-Analysis of Promoter Methylation in Eight Tumor-Suppressor Genes and Its Association With the Risk of Thyroid Cancer, PLoS ONE (2017)
10. Multiple Endocrine Neoplasia Syndromes From Genetic and Epigenetic Perspectives, Biomarker Insights (2018)
11. Oncometabolites As Biomarkers in Thyroid Cancer: A Systematic Review, Cancer Management and Research (2019)
12. A Review on the Molecular Pathology of Epithelial Thyroid Tumors, Journal of Isfahan Medical School (2018)
13. Genetic and Epigenetic Differences of Benign and Malignant Pheochromocytomas and Paragangliomas (Ppgls), Endocrine Regulations (2018)
14. Liquid Biopsy As a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations, International Journal of Molecular and Cellular Medicine (2019)
15. Germline Mutations of Ret Proto-Oncogene Exon 2 in Iranian Population With Medullary Thyroid Carcinoma, Koomesh (2016)
16. The Presence of Tumor Extrachomosomal Circular Dna (Ecdna) As a Component of Liquid Biopsy in Blood, Medical Hypotheses (2018)
17. Pi3k/Akt Pathway and Its Mediators in Thyroid Carcinomas, Molecular Diagnosis and Therapy (2016)
18. Adrenal Collision Tumor Composed of Pheochromocytoma and Diffuse Large B-Cell Lymphoma: A Case Report, International Journal of Hematology-Oncology and Stem Cell Research (2018)
19. Current Diagnostic Status of Pheochromocytomaand Future Perspective: A Mini Review, Iranian Journal of Pathology (2017)
20. The Emerging Role of Succinate Dehyrogenase Genes (Sdhx) in Tumorigenesis, International Journal of Hematology-Oncology and Stem Cell Research (2019)